Abstract
In humans, the cytoplasmic FMR1 interacting protein (CYFIP) family is composed of CYFIP1 and CYFIP2. Despite their high similarity and shared interaction with many partners, CYFIP1 and CYFIP2 act at different points in cellular processes. CYFIP1 and CYFIP2 have different expression levels in human tissues, and knockout animals die at different time points of development. CYFIP1, similar to CYFIP2, acts in the WAVE regulatory complex (WRC) and plays a role in actin dynamics through the activation of the Arp2/3 complex and in a posttranscriptional regulatory complex with the fragile X mental retardation protein (FMRP). Previous reports have shown that CYFIP1 and CYFIP2 may play roles in posttranscriptional regulation in different ways. While CYFIP1 is involved in translation initiation via the 5′UTR, CYFIP2 may regulate mRNA expression via the 3′UTR. In addition, this CYFIP protein family is involved in neural development and maturation as well as in different neural disorders, such as intellectual disabilities, autistic spectrum disorders, and Alzheimer’s disease. In this review, we map diverse studies regarding the functions, regulation, and implications of CYFIP proteins in a series of molecular pathways. We also highlight mutations and their structural effects both in functional studies and in neural diseases.
Similar content being viewed by others
References
Courchesne E, Pramparo T, Gazestani VH et al (2019) The ASD living biology: from cell proliferation to clinical phenotype. Mol Psychiatry 24:88–107. https://doi.org/10.1038/s41380-018-0056-y
Gataullina S, Bienvenu T, Nabbout R et al (2019) Gene mutations in pediatric epilepsies cause NMDA-pathy, and phasic and tonic GABA-pathy. Dev Med Child Neurol 61:891–898. https://doi.org/10.1111/dmcn.14152
Dark C, Homman-Ludiye J, Bryson-Richardson RJ (2018) The role of ADHD associated genes in neurodevelopment. Dev Biol 438:69–83. https://doi.org/10.1016/j.ydbio.2018.03.023
Zhuo C, Hou W, Li G et al (2019) The genomics of schizophrenia: shortcomings and solutions. Prog Neuropsychopharmacol Biol Psychiatry 93:71–76. https://doi.org/10.1016/j.pnpbp.2019.03.009
Gulisano W, Maugeri D, Baltrons MA et al (2018) Role of amyloid-β and tau proteins in Alzheimer’s disease: confuting the amyloid cascade. J Alzheimers Dis 64:S611–S631. https://doi.org/10.3233/JAD-179935
Pourcain BS, Robinson EB, Antilla V et al (2018) ASD and schizophrenia show distinct developmental profiles in common genetic overlap with population-based social communication difficulties. Mol Psychiatry 23:263–270. https://doi.org/10.1038/mp.2016.198
Noroozi R, Omrani MD, Sayad A et al (2018) Cytoplasmic FMRP interacting protein 1/2 (CYFIP1/2) expression analysis in autism. Metab Brain Dis 33:1353–1358. https://doi.org/10.1007/s11011-018-0249-8
Sayad A, Ranjbaran F, Ghafouri-Fard S et al (2018) Expression analysis of CYFIP1 and CAMKK2 genes in the blood of epileptic and schizophrenic patients. J Mol Neurosci 65:336–342. https://doi.org/10.1007/s12031-018-1106-2
Domínguez-Iturza N, Lo AC, Shah D et al (2019) The autism- and schizophrenia-associated protein CYFIP1 regulates bilateral brain connectivity and behaviour. Nat Commun 10:3454. https://doi.org/10.1038/s41467-019-11203-y
Clifton NE, Thomas KL, Wilkinson LS et al (2020) FMRP and CYFIP1 at the synapse and their role in psychiatric vulnerability. Complex Psychiatry. https://doi.org/10.1159/000506858
Waltes R, Freitag CM, Herlt T et al (2019) Impact of autism-associated genetic variants in interaction with environmental factors on ADHD comorbidities: an exploratory pilot study. J Neural Transm 126:1679–1693. https://doi.org/10.1007/s00702-019-02101-0
Tiwari SS, Mizuno K, Ghosh A et al (2016) Alzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss. Brain 139:2751–2765. https://doi.org/10.1093/brain/aww205
Hoeffer CA, Sanchez E, Hagerman RJ et al (2012) Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome. Genes Brain Behav 11:332–341. https://doi.org/10.1111/j.1601-183X.2012.00768.x
Han K, Chen H, Gennarino VA et al (2015) Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice. Hum Mol Genet 24:1813–1823. https://doi.org/10.1093/hmg/ddu595
Nakashima M, Kato M, Aoto K et al (2018) De novo hotspot variants in CYFIP2 cause early-onset epileptic encephalopathy. Ann Neurol 83:794–806. https://doi.org/10.1002/ana.25208
Kumar V, Kim K, Joseph C et al (2013) C57BL/6N mutation in cytoplasmic FMRP interacting protein 2 regulates cocaine response. Science 342:1508–1512. https://doi.org/10.1126/science.1245503
Kirkpatrick SL, Goldberg LR, Yazdani N et al (2017) Cytoplasmic FMR1-interacting protein 2 is a major genetic factor underlying binge eating. Biol Psychiatry 81:757–769. https://doi.org/10.1016/j.biopsych.2016.10.021
Zhang Y, Kang Hyae R, Lee SH et al (2020) Enhanced prefrontal neuronal activity and social dominance behavior in postnatal forebrain excitatory neuron-specific Cyfip2 knock-out mice. Front Mol Neurosci 13:1–10. https://doi.org/10.3389/fnmol.2020.574947
Kobayashi K, Kuroda S, Fukata M et al (1998) p140Sra-1 (specifically Rac1-associated protein) is a novel specific target for Rac1 small GTPase. J Biol Chem 273:291–295. https://doi.org/10.1074/jbc.273.1.291
Zhang Y, Kang H, Lee Y et al (2019) Smaller body size, early postnatal lethality, and cortical extracellular matrix-related gene expression changes of Cyfip2-null embryonic mice. Front Mol Neurosci 11:482. https://doi.org/10.3389/fnmol.2018.00482
Schenck A, Bardoni B, Moro A et al (2001) A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P. Proc Natl Acad Sci USA 98:8844–8849. https://doi.org/10.1073/pnas.151231598
Abekhoukh S, Bardoni B (2014) CYFIP family proteins between autism and intellectual disability: links with Fragile X syndrome. Front Cell Neurosci. https://doi.org/10.3389/fncel.2014.00081
Schaks M, Reinke M, Witke W, Rottner K (2020) Molecular dissection of neurodevelopmental disorder-causing mutations in CYFIP2. Cells 9:1355. https://doi.org/10.3390/cells9061355
Zhang Y, Kang HR, Han K (2019) Differential cell-type-expression of CYFIP1 and CYFIP2 in the adult mouse hippocampus. Anim Cells Syst 23:380–383. https://doi.org/10.1080/19768354.2019.1696406
Cioni J-M, Wong HH-W, Bressan D et al (2018) Axon–axon interactions regulate topographic optic tract sorting via CYFIP2-dependent WAVE complex function. Neuron 97:1078-1093.e6. https://doi.org/10.1016/j.neuron.2018.01.027
Didsbury J, Evans T, Snyderman R (1989) Rac, a novel ras-related family of proteins that are botulinum toxin substrates. J Biol Chem 264:5
Abo A, Pick E, Hall A et al (1991) Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature 353:668–670
Kim SK (2000) Cell polarity: new PARtners for Cdc42 and Rac. Nat Cell Biol 2:E143–E145. https://doi.org/10.1038/35019623
Castilho RM, Squarize CH, Patel V et al (2007) Requirement of Rac1 distinguishes follicular from interfollicular epithelial stem cells. Oncogene 26:5078–5085. https://doi.org/10.1038/sj.onc.1210322
Guo F, Cancelas JA, Hildeman D et al (2008) Rac GTPase isoforms Rac1 and Rac2 play a redundant and crucial role in T-cell development. Blood 112:1767–1775. https://doi.org/10.1182/blood-2008-01-132068
Ridley AJ, Paterson HF, Johnston CL et al (1992) The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70:401–410
Takenawa T, Suetsugu S (2007) The WASP–WAVE protein network: connecting the membrane to the cytoskeleton. Nat Rev Mol Cell Biol 8:37–48. https://doi.org/10.1038/nrm2069
Innocenti M, Zucconi A, Disanza A et al (2004) Abi1 is essential for the formation and activation of a WAVE2 signalling complex. Nat Cell Biol 6:319–327. https://doi.org/10.1038/ncb1105
Campellone KG, Welch MD (2010) A nucleator arms race: cellular control of actin assembly. Nat Rev Mol Cell Biol 11:237–251. https://doi.org/10.1038/nrm2867
Abekhoukh S, Sahin HB, Grossi M et al (2017) New insights into the regulatory function of CYFIP1 in the context of WAVE- and FMRP-containing complexes. Dis Model Mech 10:463–474. https://doi.org/10.1242/dmm.025809
Fricano-Kugler C, Gordon A, Shin G et al (2019) CYFIP1 overexpression increases fear response in mice but does not affect social or repetitive behavioral phenotypes. Mol Autism 10:25. https://doi.org/10.1186/s13229-019-0278-0
Verkerk AJMH, Pieretti M, Sutcliffe JS et al (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905–914. https://doi.org/10.1016/0092-8674(91)90397-H
Bagni C, Oostra BA (2013) Fragile X syndrome: from protein function to therapy. Am J Med Genet A 161A:2809–2821. https://doi.org/10.1002/ajmg.a.36241
Michaelsen-Preusse K, Feuge J, Korte M (2018) Imbalance of synaptic actin dynamics as a key to fragile X syndrome? J Physiol 596:2773–2782. https://doi.org/10.1113/JP275571
Napoli I, Mercaldo V, Boyl PP et al (2008) The fragile X syndrome protein Represses Activity-Dependent Translation through CYFIP1, a New 4E-BP. Cell 134:1042–1054. https://doi.org/10.1016/j.cell.2008.07.031
De Rubeis S, Pasciuto E, Li KW et al (2013) CYFIP1 coordinates mRNA translation and cytoskeleton remodeling to ensure proper dendritic spine formation. Neuron 79:1169–1182. https://doi.org/10.1016/j.neuron.2013.06.039
Di Marino D, D’Annessa I, Tancredi H et al (2015) A unique binding mode of the eukaryotic translation initiation factor 4E for guiding the design of novel peptide inhibitors: Cyfip1 and eIF4E Inhibitor Peptides. Protein Sci 24:1370–1382. https://doi.org/10.1002/pro.2708
Hsiao K, Harony-Nicolas H, Buxbaum JD et al (2016) Cyfip1 regulates presynaptic activity during development. J Neurosci 36:1564–1576. https://doi.org/10.1523/JNEUROSCI.0511-15.2016
Oguro-Ando A, Rosensweig C, Herman E et al (2015) Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR. Mol Psychiatry 20:1069–1078. https://doi.org/10.1038/mp.2014.124
Sahasrabudhe A, Begum F, Guevara C et al (2021) Cyfip1 regulates SynGAP1 at hippocampal synapses. Front Synaptic Neurosci 12:581714. https://doi.org/10.3389/fnsyn.2020.581714
Shen W, Jin L, Zhu A et al (2021) Treadmill exercise enhances synaptic plasticity in the ischemic penumbra of MCAO mice by inducing the expression of Camk2a via CYFIP1 upregulation. Life Sci 270:119033. https://doi.org/10.1016/j.lfs.2021.119033
Kawano Y, Yoshimura T, Tsuboi D et al (2005) CRMP-2 is involved in kinesin-1-dependent transport of the sra-1/WAVE1 complex and axon formation. Mol Cell Biol 25:9920–9935. https://doi.org/10.1128/MCB.25.22.9920-9935.2005
Dziunycz PJ, Neu J, Lefort K et al (2017) CYFIP1 is directly controlled by NOTCH1 and down-regulated in cutaneous squamous cell carcinoma. PLoS ONE 12:e0173000. https://doi.org/10.1371/journal.pone.0173000
Habela CW, Yoon K-J, Kim N-S et al (2020) Persistent Cyfip1 expression is required to maintain the adult subventricular zone neurogenic niche. J Neurosci 40:2015–2024. https://doi.org/10.1523/JNEUROSCI.2249-19.2020
Egger B, Gold KS, Brand AH (2010) Notch regulates the switch from symmetric to asymmetric neural stem cell division in the Drosophila optic lobe. Development 137:2981–2987. https://doi.org/10.1242/dev.051250
Contreras EG, Egger B, Gold KS, Brand AH (2018) Dynamic Notch signalling regulates neural stem cell state progression in the Drosophila optic lobe. Neural Dev 13:25. https://doi.org/10.1186/s13064-018-0123-8
Ghosh A, Mizuno K, Tiwari SS et al (2020) Alzheimer’s disease-related dysregulation of mRNA translation causes key pathological features with ageing. Transl Psychiatry 10:192. https://doi.org/10.1038/s41398-020-00882-7
Darnell JC, Van Driesche SJ, Zhang C et al (2011) FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146:247–261. https://doi.org/10.1016/j.cell.2011.06.013
Lee Y, Zhang Y, Kang H et al (2020) Epilepsy- and intellectual disability-associated CYFIP2 interacts with both actin regulators and RNA-binding proteins in the neonatal mouse forebrain. Biochem Biophys Res Commun 529:1–6. https://doi.org/10.1016/j.bbrc.2020.05.221
Lin J, Liao S, Li E et al (2020) circCYFIP2 acts as a sponge of miR-1205 and affects the expression of its target gene E2F1 to regulate gastric cancer metastasis. Mol Ther Nucleic Acids 21:121–132. https://doi.org/10.1016/j.omtn.2020.05.007
Liu Y, Liu H, Bian Q (2020) Identification of potential biomarkers associated with basal cell carcinoma. BioMed Res Int 2020:1–10. https://doi.org/10.1155/2020/2073690
May P, May E (1999) Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18:7621–7636. https://doi.org/10.1038/sj.onc.1203285
Jackson RS, Cho Y-J, Stein S, Liang P (2007) CYFIP2, a direct p53 target, is leptomycin-B sensitive. Cell Cycle 6:95–103. https://doi.org/10.4161/cc.6.1.3665
Ozaki T, Nakagawara A (2011) Role of p53 in cell death and human cancers. Cancers 3:994–1013. https://doi.org/10.3390/cancers3010994
Mayne M, Moffatt T, Kong H et al (2004) CYFIP2 is highly abundant in CD4+ cells from multiple sclerosis patients and is involved in T cell adhesion. Eur J Immunol 34:1217–1227. https://doi.org/10.1002/eji.200324726
Levanon EY, Halleger M, Kinar Y et al (2005) Evolutionarily conserved human targets of adenosine to inosine RNA editing. Nucleic Acids Res 33:1162–1168. https://doi.org/10.1093/nar/gki239
Nishimoto Y, Yamashita T, Hideyama T et al (2008) Determination of editors at the novel A-to-I editing positions. Neurosci Res 61:201–206. https://doi.org/10.1016/j.neures.2008.02.009
Kwak S, Nishimoto Y, Yamashita T (2008) Newly identified ADAR-mediated A-to-I editing positions as a tool for ALS research. RNA Biol 5:193–197. https://doi.org/10.4161/rna.6925
Wahlstedt H, Daniel C, Enstero M, Ohman M (2009) Large-scale mRNA sequencing determines global regulation of RNA editing during brain development. Genome Res 19:978–986. https://doi.org/10.1101/gr.089409.108
Levitsky LI, Kliuchnikova AA, Kuznetsova KG et al (2019) Adenosine-to-inosine RNA editing in mouse and human brain proteomes. Proteomics 19:1900195. https://doi.org/10.1002/pmic.201900195
Shtrichman R, Germanguz I, Mandel R et al (2012) Altered A-to-I RNA editing in human embryogenesis. PLoS ONE 7:e41576. https://doi.org/10.1371/journal.pone.0041576
Nicholas A, de Magalhaes JP, Kraytsberg Y et al (2010) Age-related gene-specific changes of A-to-I mRNA editing in the human brain. Mech Ageing Dev 131:445–447. https://doi.org/10.1016/j.mad.2010.06.001
Bonini D, Filippini A, La Via L et al (2015) Chronic glutamate treatment selectively modulates AMPA RNA editing and ADAR expression and activity in primary cortical neurons. RNA Biol 12:43–53. https://doi.org/10.1080/15476286.2015.1008365
Eden S, Rohatgi R, Podtelejnikov AV et al (2002) Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck. Nature 418:790–793. https://doi.org/10.1038/nature00859
Derivery E, Lombard B, Loew D, Gautreau A (2009) The Wave complex is intrinsically inactive. Cell Motil Cytoskelet 66:777–790. https://doi.org/10.1002/cm.20342
Gautreau A, Ho H, Li J et al (2004) Purification and architecture of the ubiquitous Wave complex. PNAS 101:4379–4383
Chen Z, Borek D, Padrick SB et al (2010) Structure and control of the actin regulatory WAVE complex. Nature 468:533–538. https://doi.org/10.1038/nature09623
Lebensohn AM, Kirshner MW (2009) Activation of the WAVE complex by coincident signals controls actin assembly. Mol Cell 36:512–524. https://doi.org/10.1016/j.molcel.2009.10.024
Takahashi K (2012) WAVE2 protein complex coupled to membrane and microtubules. J Oncol. https://doi.org/10.1155/2012/590531
Svitkina T (2018) The actin cytoskeleton and actin-based motility. Cold Spring Harb Perspect Biol 10:a018267. https://doi.org/10.1101/cshperspect.a018267
Rottner K, Schaks M (2019) Assembling actin filaments for protrusion. Curr Opin Cell Biol 56:53–63. https://doi.org/10.1016/j.ceb.2018.09.004
Schaks M, Singh SP, Kage F et al (2018) Distinct interaction sites of Rac GTPase with WAVE regulatory complex have non-redundant functions in vivo. Curr Biol 28:3674-3684.e6. https://doi.org/10.1016/j.cub.2018.10.002
Chen B, Chou H-T, Brautigam CA et al (2017) Rac1 GTPase activates the WAVE regulatory complex through two distinct binding sites. Elife 6:1–22. https://doi.org/10.7554/eLife.29795
Lee Y, Kim D, Ryu JR et al (2017) Phosphorylation of CYFIP2, a component of the WAVE-regulatory complex, regulates dendritic spine density and neurite outgrowth in cultured hippocampal neurons potentially by affecting the complex assembly. NeuroReport 28:749–754
Marsden KC, Jain RA, Wolman MA et al (2018) A Cyfip2-dependent excitatory interneuron pathway establishes the innate startle threshold. Cell Rep 23:878–887. https://doi.org/10.1016/j.celrep.2018.03.095
Konietzny A, Bär J, Mikhaylova M (2017) Dendritic actin cytoskeleton: structure, functions, and regulations. Front Cell Neurosci 11:147. https://doi.org/10.3389/fncel.2017.00147
Alvarez VA, Sabatini BL (2007) Anatomical and physiological plasticity of dendritic spines. Annu Rev Neurosci 30:79–97. https://doi.org/10.1146/annurev.neuro.30.051606.094222
Koseki K, Taniguchi D, Yamashiro S et al (2019) Lamellipodium tip actin barbed ends serve as a force sensor. Genes Cells 24:705–718. https://doi.org/10.1111/gtc.12720
Pathania M, Davenport EC, Muir J et al (2014) The autism and schizophrenia associated gene CYFIP1 is critical for the maintenance of dendritic complexity and the stabilization of mature spines. Transl Psychiatry 4:e374–e374. https://doi.org/10.1038/tp.2014.16
Kulkarni VA, Firestein BL (2012) The dendritic tree and brain disorders. Mol Cell Neurosci 50:10–20. https://doi.org/10.1016/j.mcn.2012.03.005
Sledziowska M, Kalbassi S, Baudouin SJ (2020) Complex interactions between genes and social environment cause phenotypes associated with autism spectrum disorders in mice. eNeuro 7:1–15. https://doi.org/10.1523/ENEURO.0124-20.2020
Butler MG (2017) Clinical and genetic aspects of the 15q11.2 BP1-BP2 microdeletion disorder: 15q11.2 BP1-BP2 microdeletion. J Intellect Disabil Res 61:568–579. https://doi.org/10.1111/jir.12382
Silva AI, Haddon JE, Ahmed Syed Y et al (2019) Cyfip1 haploinsufficient rats show white matter changes, myelin thinning, abnormal oligodendrocytes and behavioural inflexibility. Nat Commun 10:3455. https://doi.org/10.1038/s41467-019-11119-7
Zuchero JB, Fu M, Sloan SA et al (2015) CNS myelin wrapping is driven by actin disassembly. Dev Cell 34:152–167. https://doi.org/10.1016/j.devcel.2015.06.011
Babbs RK, Beierle JA, Ruan QT et al (2019) Cyfip1 haploinsufficiency increases compulsive-like behavior and modulates palatable food intake in mice: dependence on Cyfip2 genetic background, parent-of origin, and sex. Genes Genet Genome 9:3009–3022. https://doi.org/10.1534/g3.119.400470
Faye MD, Graber TE, Holcik M (2014) Assessment of selective mRNA translation in mammalian cells by polysome profiling. J Vis Exp 92:e52295. https://doi.org/10.3791/52295
Kim GH, Zhang Y, Kang HR (2020) Altered presynaptic function and number of mitochondria in the medial prefrontal cortex of adult Cyfip2 heterozygous mice. Mol Brain 13:123. https://doi.org/10.1186/s13041-020-00668-4
Hoover BR, Reed MN, Su J et al (2010) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68:1067–1081. https://doi.org/10.1016/j.neuron.2010.11.030
Islam T (2016) Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders. Neurol Res 39:73–82. https://doi.org/10.1080/01616412.2016.1251711
Peng J, Wang Y, He F et al (2018) Novel West syndrome candidate genes in a Chinese cohort. CNS Neurosci Ther 24:1196–1206. https://doi.org/10.1111/cns.12860
Zweier M, Begemann A, McWalter K et al (2019) Spatially clustering de novo variants in CYFIP2, encoding the cytoplasmic FMRP interacting protein 2, cause intellectual disability and seizures. Eur J Hum Genet 27:747–759. https://doi.org/10.1038/s41431-018-0331-z
Zhong M, Liao S, Li T et al (2019) Early diagnosis improving the outcome of an infant with epileptic encephalopathy with cytoplasmic FMRP interacting protein 2 mutation: case report and literature review. Medicine (Baltimore) 98:e17749. https://doi.org/10.1097/MD.0000000000017749
Begeman A, Sticht H, Begtrup A et al (2020) New insights into the clinical and molecular spectrum of the novel CYFIP2-related neurodevelopmental disorder and impairment of the WRC-mediated actin dynamics. Genet Med 23:543–554. https://doi.org/10.1038/s41436-020-01011-x
Zhang Y, Lee Y, Han K (2019) Neuronal function and dysfunction of CYFIP2: from actin dynamics to early infantile epileptic encephalopathy. BMB Rep 52:304–311. https://doi.org/10.5483/BMBRep.2019.52.5.097
Lee SH, Zhang Y, Park J et al (2020) Haploinsufficiency of Cyfip2 causes lithium-responsive prefrontal dysfunction. Ann Neurol 00:1–18. https://doi.org/10.1002/ana.25827
Funding
CNPq/Instituto Carlos Chagas Nº 15/2019—PROEP/ICC—442324/2019-7.
Author information
Authors and Affiliations
Contributions
ÍVB and ILZS contributed to the study conception and design, performed the literature search, and wrote the original manuscript. PS and TACBS critically revised the work. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any results with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Biembengut, Í.V., Silva, I.L.Z., Souza, T.d.A.C.B.d. et al. Cytoplasmic FMR1 interacting protein (CYFIP) family members and their function in neural development and disorders. Mol Biol Rep 48, 6131–6143 (2021). https://doi.org/10.1007/s11033-021-06585-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-021-06585-6